POGO

  • Staff List
  • Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Multidisciplinary Symposium on Childhood Cancer
    • POGO Virtual Education
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

Blog

POGO > Blog > cisplatin-induced hearing loss
[sharethis]

Tag: cisplatin-induced hearing loss


Genetic Predictors of Adverse Outcomes

Posted on February 7, 2013 by admin

Presentation Description: Advances in the treatment of pediatric cancer have resulted in significant improvements in cure rates and presently over 80% of children with cancer will be cured of their disease.  Unfortunately, this improvement has come at a significant cost as a large proportion of children are left with significant late effects that cause significant life-long morbidity and even mortality.  Therefore, a recent focus of research in pediatric oncology has been to investigate outcomes in long term survivors, in order to try and eliminate these late effects. The recent advances in genomic technology have allowed researchers to begin to try to unravel the causes of treatment toxicity, and to answer the question of why one child has a devastating complication of therapy, while a similar child receiving the same treatment does not have any toxicity. This presentation highlighted many of the recent advances in the understanding of drug toxicity in pediatric cancer, and specifically looked at three late effects: cisplatin-induced hearing loss, cardiac toxicity due to anthracyclines, and radiation and chemotherapy induced second malignancies.

Speaker:

Rod Rassekh, MD, MHSc
Clinical Assistant Professor, University of British Columbia Vancouver, BC
Pediatric Oncologist, BC Children’s Hospital, Vancouver, BC

Posted in 2012 AfterCare Education Day, Education for Health Professionals | Tagged 2012 AfterCare Education Day, AfterCare, anthracycline-associated cardiotoxicity, cisplatin-induced hearing loss, genetics, late effects, second malignancies, survivorship

Donate

Blog

Education Portal
Survivor Conference
All Categories

Categories

Newsletter Sign-Up

Please leave this field empty

@POGO4Kids

May 12, 2022

Take your Half Marathon, 10k or 5k training one step further! @POGO4kids builds a childhood cancer care system for children, youth, families & survivors affected by childhood cancer. TWRS runners can support POGO with their own fundraising page.

For more: https://www.towomensruns.com/fundraising/

Reply on Twitter 1524902320689106973Retweet on Twitter 15249023206891069732Like on Twitter 15249023206891069737

Follow @POGO4Kids

Quick Links

  • For Professionals
    • Read Cancer Care Plan
    • Review our Guidelines
    • Request Research Data
  • Families & Kids
    • Get POGO AfterCare
    • Meet with a POGO Nurse
    • Get Care Closer to Home
  • For Survivors
    • Find Local Resources
    • Set Goals for your Future
    • Educate Yourself
  • Get Involved
    • Host an Event for POGO
    • Volunteer with POGO
    • Partner with POGO
  • About Us
    • Our Mission and Vision
    • Childhood Cancer Care Plan
    • POGO Land Acknowledgement
    • Diversity, Equity, Inclusion
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Accessibility
    • Reports
    • Newsroom
    • Job Opportunities
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Multidisciplinary Symposium on Childhood Cancer
    • POGO Virtual Education
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2021 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 |
1-855-FOR POGO (367-7646) | Contact Us | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |